Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis
Date
2021Journal
World Journal of Emergency MedicinePublisher
Second Affiliated Hospital, Zhejiang University School of MedicineType
Article
Metadata
Show full item recordKeyword
cannabinoid hyperemesis syndromeintractable vomiting
Gastroparesis
Haloperidol--therapeutic use
Identifier to cite or link to this item
http://hdl.handle.net/10713/16625ae974a485f413a2113503eed53cd6c53
10.5847/wjem.j.1920-8642.2021.03.012
Scopus Count
Collections
Related articles
- Randomized Controlled Double-blind Trial Comparing Haloperidol Combined With Conventional Therapy to Conventional Therapy Alone in Patients With Symptomatic Gastroparesis.
- Authors: Roldan CJ, Chambers KA, Paniagua L, Patel S, Cardenas-Turanzas M, Chathampally Y
- Issue date: 2017 Nov
- Gastroparesis-associated refractory nausea treated with aprepitant.
- Authors: Fahler J, Wall GC, Leman BI
- Issue date: 2012 Dec
- Paraneoplastic rhombencephalitis and cerebellitis preceded by isolated intractable vomiting.
- Authors: Renard D, Castelnovo G, Bories C, Rieux C, Bernard-Decot C
- Issue date: 2017 Sep
- Gastric electrical stimulation in intractable symptomatic gastroparesis.
- Authors: Abell TL, Van Cutsem E, Abrahamsson H, Huizinga JD, Konturek JW, Galmiche JP, VoelIer G, Filez L, Everts B, Waterfall WE, Domschke W, Bruley des Varannes S, Familoni BO, Bourgeois IM, Janssens J, Tougas G
- Issue date: 2002
- Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department.
- Authors: Ramirez R, Stalcup P, Croft B, Darracq MA
- Issue date: 2017 Aug